| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
3.1 -0.04 (-0.01%) |
07-19 16:00 |
|
Open: |
3.11 |
Pre close: |
3.14 |
Target:
|
3.77 
|
|
High: |
3.17 |
Low: |
3.08 |
Resistance:
|
3.22
3.40
|
|
Volume: |
77,762 |
Market Cap: |
297M |
Support:
|
2.94
2.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.17
|
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
3.10 |
Signal(12,26,9): |
-0.00  |
|
MA(100): |
3.19 |
Stochastic Oscillator |
%K(14,3):
|
44.93 |
|
MA(250): |
4.12 |
%D(3): |
52.95 |
|
Average Volume(K) |
3-Month: |
15929
|
52-Week |
High:
|
8.89 |
|
10-Days: |
14535 |
Low: |
2.73 |
|
RSI |
RSI(14):
|
47.36 |
Change(%): |
-57.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.353 |
Return on Equity (ttm) |
-33.4 |
Shares Out. (M) |
95.72 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-19.6 |
Shares Float (M) |
35.28 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.36 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.00 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4800 |
|
Book Value (p.s.) |
1.090 |
EBITDA (p.s.) |
-0.312 |
P/E |
-8.78 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.84 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-27.84 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.28 |
P/CF |
-10.66 |
|
|
|
|
|
|
